Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year.
Dogecoin’s Chart Prompts Bullish Predictions: ‘Fun Doesn’t Begin Until $0.25,’ Says Trader
Dogecoin (CRYPTO: DOGE) is surrounded by bullish sentiment ahead of DOGE Day, scheduled for April 20, enjoying positive investor sentiment.
